Hiroshi Miyama

Dr. Hiroshi Miyama

Keio University School of Medicine, Department of Cardiology
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HMHiroshi Miyama
Hiroshi Miyama
YSYasuyuki Shiraishi
Yasuyuki Shiraishi
SKShun Kohsaka
Shun Kohsaka
AGAyumi Goda
Ayumi Goda
YNYosuke Nishihata
Yosuke Nishihata
TYTsutomu Yoshikawa
Tsutomu Yoshikawa
Abnormal liver function tests (LFTs) are known to be associated with impaired clinical outcomes in heart failure (HF) patients. However, this implication varies with each single LFT panel. We aim to evaluate the long-term outcomes of acute HF (AHF) patients by assessing multiple LFT panels in combination. From a prospective multicenter registry in Japan, 1158 AHF patients who were successfully discharged were analyzed (mean age, 73.9 ± 13.5 years; men, 58%). LFTs (i.e., total bilirubin, aspartate aminotransferase or alanine aminotransferase, and alkaline phosphatase) at discharge were assessed; borderline and abnormal LFTs were defined as 1 and ≥2 parameter values above the normal range, respectively. The primary endpoint was composite of all-cause death or HF readmission. At the time of discharge, 28.7% and 8.6% of patients showed borderline and abnormal LFTs, respectively. There were 196 (16.9%) deaths and 298 (25.7%) HF readmissions during a median 12.4-month follow-up period. The abnormal LFTs group had a significantly higher risk of experiencing the composite outcome (adjusted hazard ratio: 1.51, 95% confidence interval: 1.08–2.12, p = 0.017), whereas the borderline LFTs group was not associated with higher risk of adverse events when referenced to the normal LFTs group. Among AHF patients, the combined elevation of ≥2 LFT panels at discharge was associated with long-term adverse outcomes.

8 April 2024 in Heart Rhythm
Verified
Journal Article
Closed access
HMHiroshi Miyama
Hiroshi Miyama
NINobuhiro Ikemura
Nobuhiro Ikemura
TKTakehiro Kimura
Takehiro Kimura
YKYoshinori Katsumata
Yoshinori Katsumata
SYShuhei Yamashita
Shuhei Yamashita
MIMasaki Ieda
Masaki Ieda

19 September 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
HMHiroshi Miyama
Hiroshi Miyama
STSeiji Takatsuki
Seiji Takatsuki
NINobuhiro Ikemura
Nobuhiro Ikemura
TKTakehiro Kimura
Takehiro Kimura
YKYoshinori Katsumata
Yoshinori Katsumata
SKShun Kohsaka
Shun Kohsaka
Background: Catheter ablation (CA) for atrial fibrillation (AF) is preferred for paroxysmal AF (PAF) but selectively performed in patients with persistent AF (PersAF). This study aimed to investigate the prognostic differences and consequences of CA based on the AF type. Methods and Results: Data from a multicenter AF cohort study were analyzed, categorizing patients as PAF or PersAF according to AF duration (≤7 or >7 days, respectively). A composite of all‐cause death, heart failure hospitalization, stroke, and bleeding events during 2‐year follow‐up and changes in the Atrial Fibrillation Effect on Quality‐of‐life score were compared. Additionally, propensity score matching was performed to compare clinical outcomes of patients with and without CA in both AF types. Among 2788 patients, 51.6% and 48.4% had PAF and PersAF, respectively. Patients with PersAF had a higher incidence of the composite outcome (12.8% versus 7.2%; P <0.001) and smaller improvements in Atrial Fibrillation Effect on Quality‐of‐life scores than those with PAF. After adjusting for baseline characteristics, PersAF was an independent predictor of adverse outcomes (adjusted hazard ratio, 1.35 [95% CI, 1.30–1.78], P =0.031) and was associated with poor improvements in Atrial Fibrillation Effect on Quality‐of‐life scores. Propensity score matching analysis showed that the CA group had significantly fewer adverse events than the medication group among patients with PAF (odds ratio, 0.31 [95% CI, 0.18–0.68]; P =0.002). Patients with PersAF showed a similar but nonsignificant trend. Conclusions: PersAF is a risk factor for worse clinical outcomes, including patients' health status. CA is associated with fewer adverse events, although careful consideration is required based on the AF type.

15 December 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RNRyo Nakamaru
Ryo Nakamaru
NINobuhiro Ikemura
Nobuhiro Ikemura
TKTakehiro Kimura
Takehiro Kimura
YKYOSHINORI KATSUMATA
YOSHINORI KATSUMATA
CSCharles Fox Sherrod
Charles Fox Sherrod
SKShun Kohsaka
Shun Kohsaka
Aims: The discontinuation of oral anticoagulants (OACs) remains as a significant concern in the management of atrial fibrillation (AF). The discontinuation rate may vary depending on management strategy, and physicians may also discontinue OACs due to concerns about patient satisfaction with their care. We aimed to assess the incidence of OAC discontinuation and its relationship to patients’ health in an outpatient AF registry. Methods and Results: From a multicenter registry for newly recognized AF patients (n = 3313), we extracted 1647 (49.7%) patients with OACs and a CHA2DS2-Vasc score of ≥2. Discontinuation was defined as sustained cessation of OACs within a 1-year follow-up. We examined predictors associated with discontinuation and its relations to health status defined by the AFEQT questionnaire. Of the 1647 patients, 385 (23.6%) discontinued OACs after 1 year, with discontinuation rates varying across treatment strategies (15.3% for catheter ablation, 4.9% for rhythm control with antiarrhythmic drugs, and 3.0% for rate control). Successful rhythm control was associated with discontinuation in the catheter ablation (OR 6.61, 95% CI 3.00–14.6, p < 0.001) and antiarrhythmic drugs (OR 6.47, 95% CI 2.62–15.9, p < 0.001) groups, whereas the incidence of bleeding events within 1 year was associated with discontinuation in the rate control group. One-year AFEQT scores did not significantly differ between patients who discontinued OACs and those who did not in each treatment strategy group. Conclusions: OAC discontinuation was common among AF patients with significant stroke risk but varied depending on the chosen treatment strategy. This study also found no significant association between OAC discontinuation and patients’ health status.

1 April 2004 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
KKKazuhiko Kyoshima
Kazuhiko Kyoshima
TKTakayuki Kuroyanagi
Takayuki Kuroyanagi
TTToshihide Toriyama
Toshihide Toriyama
TTTakeomi Takizawa
Takeomi Takizawa
YHYunoshin Hirooka
Yunoshin Hirooka
SOSusumu Oikawa
Susumu Oikawa

3 July 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
KHKenji Hashimoto
Kenji Hashimoto
TKTakehiro Kimura
Takehiro Kimura
YSYuta Seki
Yuta Seki
SISusumu Ibe
Susumu Ibe
TYTerumasa Yamashita
Terumasa Yamashita
STSeiji Takatsuki
Seiji Takatsuki
Linear lesions are routinely created by radiofrequency catheter ablation. Unwanted electrical conduction gaps can be produced and are often difficult to ablate. This study aimed to clarify the characteristics of conduction gaps during atrial fibrillation ablation by analysing bidirectional activation maps using a high-density mapping system (RHYTHMIA). This retrospective study included 31 patients who had conduction gaps along pulmonary vein (PV) isolation or box ablation lesions. Activation maps were sequentially created during pacing from the coronary sinus and PV to reveal the earliest activation site, defined by the entrance and exit. The locations, length between the entrance and exit (gap length), and direction were analysed. Thirty-four bidirectional activation maps were drawn: 21 were box isolation lesions (box group), and 13 were PV isolation lesions (PVI group). Among the box group, nine conduction gaps were present in the roof region and 12 in the bottom region, while nine in right PV and four in left PV among the PVI group. Gap lengths in the roof region were longer than those in the bottom region (26.8 ± 11.8 vs. 14.5 ± 9.8 mm; P = 0.022), while those in right PV tended to longer than those in left PV (28.0 ± 15.3 vs. 16.8 ± 8.0 mm, P = 0.201). The entrances and exits of electrical conduction gaps were separated, especially in the roof region, indicating that epicardial conduction might contribute to gap formation. Identifying the bidirectional conduction gap might indicate the location and direction of epicardial conduction. Bidirectional activation maps for conduction gap at roof and bottom are shown. The length between the entrance and exit (gap length) is longer at roof line than bottom line (26.8 ± 11.8 vs. 14.6 ± 9.8 mm, P = 0.022).